Exosomes released from M2 macrophages transfer miR-221-3p contributed to EOC progression through targeting CDKN1B

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• Epithelial ovarian cancer (EOC) characteristically metastasizes to the peritoneum.
• The peritoneal immune microenvironment, particularly M2 macrophages (tumor-associated macrophages, TAMs), is critical for EOC progression.
• Exosomes mediate communication between TAMs and EOC cells, influencing tumor development.

Purpose of the Study:

• To investigate the role of exosomal microRNAs in TAM-EOC cell communication.
• To identify specific microRNAs enriched in M2 exosomes and their functional targets in EOC.

Main Methods:

• Microarray analysis of exosomes to identify enriched microRNAs.
• Directly assessing the effect of miR-221-3p on EOC cell proliferation and cell cycle.
• Analyzing the correlation between CDKN1B levels, EOC progression, and patient prognosis.

Main Results:

• Microarray analysis revealed enrichment of miR-221-3p in M2 exosomes.
• miR-221-3p was found to directly suppress cyclin-dependent kinase inhibitor 1B (CDKN1B).
• Suppression of CDKN1B by miR-221-3p promoted EOC cell proliferation and G1/S transition, with low CDKN1B correlating with poor prognosis.

Conclusions:

• TAM-derived exosomal miR-221-3p regulates EOC progression by targeting CDKN1B.
• Exosomal microRNAs, such as miR-221-3p, represent promising novel diagnostic biomarkers and therapeutic targets for EOC.